Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.2% - Should You Sell? - MarketBeat
59 minutes ago • Google News
Olema Pharmaceuticals Inc (OLMA)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 510.64M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 13.93
52W Low
$ 2.86
Dividend Yield
0.00%
Beta
1.94
Technicals
50-Day MA
5.243
200-Day MA
5.3372
52 Week High
13.93
52 Week Low
2.86
About OLMA
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers.
Employees
116
Headquarters
San Francisco, CA
CEO
Dr. Sean P. Bohen M.D., Ph.D.